Full metadata record

DC Field Value Language
dc.contributor.authorLim Jin Hong-
dc.contributor.authorPark, Keun wan-
dc.contributor.authorChoi Kyung Hwa-
dc.contributor.authorKim Chan Wung-
dc.contributor.authorLee Jae Ha-
dc.contributor.authorWeicker Raymond-
dc.contributor.authorPAN, CHEOL HO-
dc.contributor.authorKim Seok-Mo-
dc.contributor.authorPark Ki Cheong-
dc.date.accessioned2024-01-12T03:01:31Z-
dc.date.available2024-01-12T03:01:31Z-
dc.date.created2022-08-09-
dc.date.issued2022-07-
dc.identifier.issn1661-6596-
dc.identifier.urihttps://pubs.kist.re.kr/handle/201004/76665-
dc.description.abstractDrug resistance causes therapeutic failure in refractory cancer. Cancer drug resistance stems from various factors, such as patient heterogeneity and genetic alterations in somatic cancer cells, including those from identical tissues. Generally, resistance is intrinsic for cancers; however, cancer resistance becomes common owing to an increased drug treatment. Unfortunately, overcoming this issue is not yet possible. The present study aimed to evaluate a clinical approach using candidate compounds 19 and 23, which are sarcoplasmic/endoplasmic reticulum calcium ATPase (SERCA) inhibitors, discovered using the evolutionary chemical binding similarity method. mRNA sequencing indicated SERCA as the dominant marker of patient-derived anti-cancer drug-resistant hepatocellular carcinoma (HCC), but not of patient-derived anti-cancer drug-sensitive HCC. Candidate compounds 19 and 23 led to significant tumor shrinkage in a tumor xenograft model of anti-cancer drug-resistant patient-derived HCC cells. Our results might be clinically significant for the development of novel combinatorial strategies that selectively and efficiently target highly malignant cells such as drug-resistant and cancer stem-like cells.-
dc.languageEnglish-
dc.publisherMultidisciplinary Digital Publishing Institute (MDPI)-
dc.titleDrug Discovery Using Evolutionary Similarities in Chemical Binding to Inhibit Patient-Derived Hepatocellular Carcinoma-
dc.typeArticle-
dc.identifier.doi10.3390/ijms23147971-
dc.description.journalClass1-
dc.identifier.bibliographicCitationInternational Journal of Molecular Sciences, v.23, no.14-
dc.citation.titleInternational Journal of Molecular Sciences-
dc.citation.volume23-
dc.citation.number14-
dc.description.isOpenAccessY-
dc.description.journalRegisteredClassscie-
dc.description.journalRegisteredClassscopus-
dc.identifier.wosid000833696100001-
dc.relation.journalWebOfScienceCategoryBiochemistry & Molecular Biology-
dc.relation.journalWebOfScienceCategoryChemistry, Multidisciplinary-
dc.relation.journalResearchAreaBiochemistry & Molecular Biology-
dc.relation.journalResearchAreaChemistry-
dc.type.docTypeArticle-
dc.subject.keywordPlusCA2+ HOMEOSTASIS-
dc.subject.keywordPlusOVARIAN-CANCER-
dc.subject.keywordPlusCALCIUM PUMPS-
dc.subject.keywordPlusAPOPTOSIS-
dc.subject.keywordPlusRESISTANCE-
dc.subject.keywordPlusSERCA-
dc.subject.keywordPlusCHEMOTHERAPY-
dc.subject.keywordPlusMITOCHONDRIA-
dc.subject.keywordPlusNEOADJUVANT-
dc.subject.keywordPlusSTRESS-
dc.subject.keywordAuthorcandidate 19-
dc.subject.keywordAuthorcandidate 23-
dc.subject.keywordAuthorcancer stem cells-
dc.subject.keywordAuthorpatient-derived anti-cancer drug-resistant hepatocellular carcinoma-
dc.subject.keywordAuthorendoplasmic reticulum stress-
dc.subject.keywordAuthorsarcoplasmic-
dc.subject.keywordAuthorendoplasmic reticulum calcium ATPase-
dc.subject.keywordAuthorthapsigargin-
Appears in Collections:
KIST Article > 2022
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE